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Introduction: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative 
disorder characterized by progressive loss of motor neuron. The motor unit 
number index (MUNIX) is a novel diagnostic technique developed to quantify 
axonal loss in ALS patients. The objective of this study was to establish the 
reproducibility and usefulness of the MUNIX using the abductor digiti minimi 
(ADM) and tibialis anterior (TA) muscles in ALS patients and normal 
controls. 
Methods: The MUNIX values were obtained from bilateral ADM and TA 
muscles in 30 ALS patients and 27 normal controls. The MUNIX, compound 
muscle action potential (CMAP), Medical Research Council (MRC) sum 
score, and ALS functional rating scale (ALSFRS) were evaluated, and their 
correlations were examined by using Pearson correlation analysis. All muscles 
were recorded twice to assess the reproducibility and coefficient of variation 
(COV). The mean values of all 4 (bilateral ADM and TA) muscles were 
obtained, and their correlations with functional status were analyzed. 
Results: The mean values of CMAP amplitude and MUNIX showed no 
significant difference. The COVs for CMAP and MUNIX were within the 
acceptable range of less than 20%. There was a significant correlation 
between MUNIX and CMAP amplitude in both ADM (r = 0.918, P < 0.01) 
and TA (r = 0.850, P < 0.01) muscles in ALS patients. In normal controls, 
there was also a significant correlation between MUNIX and CMAP 
amplitude in both ADM (r = 0.629, P < 0.01) and TA (r = 0.894, P < 0.01) 
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muscles. In ALS patients, MUNIX values significantly correlated with 
ALSFRS scores in the ADM (r = 0.439, P = 0.015), but not in the TA (r = 
0.357, P= 0.053). There was a significant correlation between MUNIX and 
MRC sum score in the TA (r = 0.474, P < 0.01), but not in ADM (r = 0.349, P 
= 0.058). Using the mean values of all 4 muscles, there was a more significant 
correlation between CMAP and MRS sum score (r = 0.480, P < 0.01), and 
between CMAP and ALSFRS (r = 0.517, P < 0.01). There was also a more 
significant correlation between MUNIX and MRS sum score (r = 0.493, P < 
0.01) and between MUNIX and ALSFRS (r = 0.481, P < 0.01). 
Conclusions: This study demonstrated the reproducibility of the MUNIX 
using ADM and TA muscles. Both ADM and TA muscles showed good 
correlations, but their patterns of correlations in the MUNIX were slightly 
different. The overall mean value of the 4 muscles was more useful for 
assessing functional status and disease progression. Further prospective 
follow-up studies with a larger sample size are needed to confirm our results. 
 
------------------------------------- 
Keywords: ALS, compound muscle action potential, MUNIX, abductor 
digiti minimi, tibialis anterior  
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder 
characterized by progressive loss of upper and lower motor neurons, with a 
median survival of 2-3 years (1). The incidence of ALS is fairly uniform at 
about 2-6 per 100,000 person-years (2). There is no standard treatment for 
ALS. Prediction of prognosis and survival is important for the appropriate 
treatment of individual patients. 
There are few diagnostic studies for evaluating disease progression or 
predicting progression. Although the needle electromyography (EMG) 
technique is a gold standard for the diagnosis of ALS, it is difficult to apply in 
the early stages of disease and is not efficient for the follow up of disease 
progression. EMG is also partially invasive and time-consuming method. For 
the quantification of motor unit loss of an ALS patient, the motor unit number 
estimation (MUNE) technique had been used. The MUNE technique has the 
advantage of revealing motor neuron loss in the early stages of ALS, while the 
compound muscle action potential (CMAP) amplitude does not change until 
50% of motor units are lost. Unfortunately, the MUNE technique is difficult to 
perform and time consuming, allowing only a few muscles to be studied in a 
clinical setting (3).  
The motor unit number index (MUNIX) is a novel electrophysiologic 
technique that can be used to study the number of motor units in a muscle. 
The major advantages of the MUNIX technique are that it is noninvasive, 
quick to perform, and technically not very challenging and that it can be 
2 
 
applied to any muscle in which CMAPs after supramaximal electrical 
stimulation can be evoked (4). MUNE and MUNIX values have been shown 
to decline in ALS patients more rapidly than strength, and to predict disease 
course. Therefore, these techniques are more useful for predicting disease 
progression rather than for predicting the early stages of ALS (5), (6). 
Recently, some studies have demonstrated the reproducibility and feasibility 
of the MUNIX in ALS patients and normal controls (7). Also, other studies 
have shown that the MUNIX can serve as a potential biomarker of disease 
progression (8). However, previous studies of the MUNIX in ALS patients 
have only been performed in the abductor digiti minimi (ADM) muscle (9). 
Although there have been some MUNIX measurements in the abductor 
pollicis brevis, abductor digiti minimi, biceps brachii, tibialis anterior, 
abductor hallucis, and extensor digitorum brevis muscles of normal controls 
(10), there have been few studies to evaluate the MUNIX of the lower 
extremities or large muscles in ALS patients. ALS patients can be divided into 
subtypes according to symptom onset sites: bulbar, cervical, thoracic, and 
lumbosacral. They have various types of onset symptoms related to onset 
regions. Indeed, some ALS patients have good thenar muscle power in early 
stages, while others do not. Therefore, it is important to study the MUNIX of 
large muscles in ALS patients to reflect the overall function. A previous study 
showed the usefulness and reproducibility of the MUNIX in a large muscle, 
the tibialis anterior (TA) muscle in prior polio (11). However, there have been 
few studies on the usefulness of MUNIX of larger muscles in ALS patients. 
Each ALS patient has different onset regions and the spreading pattern of 
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symptoms is slightly different. Ideally, the MUNIX of muscles in all 4 
extremities in combination with other methods will be helpful in assessing 
disease progression more precisely. 
The aim of this study was to evaluate the reproducibility of MUNIX 
measurements in the TA muscle compared to the ADM muscle and the 





ALS patients and healthy volunteers were recruited from the ALS clinic of 
Seoul National University Hospital between June 2013 and September 2013. 
Thirty patients (11 women and 19 men; age, 27-77 years) diagnosed with 
probable laboratory-supported, probable, or definite ALS according to the 
revised El Escorial criteria (12) were included. Patients who [1] were 
clinically severely affected (MRC grade ≤1), [2] were on a ventilator, or [3] 
had cognitive dysfunction were excluded. In this study, 27 healthy volunteers 
(13 women and 14 men; age, 27-75 years) were included as controls. There 
was no significant age difference between the ALS patients and healthy 
controls. There were no other neuromuscular diseases in patients and healthy 
controls. The baseline characteristics of ALS patients and normal controls are 
listed in Table 1. All patients and normal subjects were enrolled after written 
informed consents were obtained. This study was approved by the 
Institutional Review Board of Seoul National University Hospital. 
 
Muscle strength and functional assessment 
Maximal muscle strength was measured according to the Medical Research 
Council (MRC) scale. Grades 3 and 4 were described in more detail, and the + 
and – were also added. The same investigator graded bilateral shoulder 
abduction, elbow flexion, wrist extension, hip flexion, knee extension, and 
foot dorsiflexion (range, 0-5). The MRC sum score was calculated by 
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summing all 12 MRC grades (maximums 60). The ALS functional rating 
scale (ALSFRS) (range, 0-48) was used to score daily life activities (13).  
 
Electrophysiologic measurement 
MUNIX measurements were made with a commercially available EMG 
instrument (Synergy; Oxford Instruments, Hawthorne, NY). All 
measurements were made by skilled EMG technicians. First, surface EMG 
interference patterns (SIP) were recorded during voluntary muscle contraction 
against resistance provided by an operator. Two series of SIP recordings were 
obtained each at 5 increasing force levels (minimal, 25%, 50%, submaximal, 
and maximal levels).  
To evaluate reproducibility, we recorded CMAP and the MUNIX twice. The 
retest was performed by the same operator. The time between these 
investigations was 15 minutes or more. No marks were made for recording 
electrode positions.  
MUNIX measurements were performed in 4 (bilateral ADM and TA) 
muscles of each patient and control subject. The signals were saved to a hard 
disk and then analyzed offline using the “MUNIX” program, which is a DOS-
based share-ware developed by Nandedkar et al. (14).  
 
Statistical analysis 
The percentage variation in MUNIX values in each muscle was computed as 
the difference between the 2 measurements divided by their mean (3). The 
coefficient of variation (COV) was obtained as follows: 
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COV = 100 Ⅹ Abs{(MUNIX2 – MUNIX1)/[(MUNIX1 + MUNIX2)/2]} 
where “Abs” is the absolute value, and MUNIX1 and MUNIX2 are the 2 
MUNIX measurement. CMAP variability was quantified in the same way. 
To evaluate the association between MUNIX and CMAP/MRC grade in each 
muscle, the ADM and TA muscles were grouped separately. Correlation 
coefficients for trial pairs (MUNIX vs. CMAP/MRC sum score/ALSFRS) 
were evaluated by using Pearson correlation analysis in each group. For the 
analysis of correlations between MUNIX and MRC sum score/ALSFRS, the 
mean value of bilateral muscles was used. Finally, the mean MUNIX value of 
the 4 muscles (bilateral ADM and TA) was used to assess the usefulness of the 
combinations, and correlation coefficients were also evaluated. A P value of 
<0.05 was considered statistically significant. The computer software package 















The clinical characteristics and mean values of CMAP and MUNIX in both 
ALS patients and normal controls are summarized in Table 1. The mean age 
was 57.33 years (range, 31-77 years) in ALS patients, and it was 55.04 years 
(range, 27-75 years) in normal controls. The mean duration of symptom of 
ALS patients were 15.5 months (range, 3-41 months). CMAP amplitudes and 
MUNIX measurements were significantly lower in ALS patients than in 
normal controls in all muscles. The mean MRC sum score was 49.2 points 
(range, 23-59 points) and the mean ALSFRS score was 35.7 points (range, 16-
45 points).  The demographics of the patients are summarized in Table 2, 
and their MUNIX and CMAP results of the ADM and TA muscles are shown 
in Tables 3 and 4, respectively. According to the El Escorial criteria, 7 of the 
30 patients were diagnosed with definite ALS, 13 were diagnosed with 
probable ALS, and 10 were diagnosed with probable laboratory-supported 
ALS. Onset symptoms developed from the bulbar segment in 5 patients, from 
the cervical segment in 19 patients, and from the lumbosacral segment in 6 
patients. 
 The mean values of CMAP amplitude and MUNIX showed no significant 
difference. The reproducibility of MUNIX and CMAP amplitude is 
summarized in Table 5. The COVs for CMAP and MUNIX were within the 
acceptable range of less than 20% in ALS patients and normal controls. In 
ALS patients, the COVs were higher in the ADM muscle than in the TA 
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muscle, whereas in normal controls they were higher in the TA muscle than in 
the ADM muscle. Correlations between MUNIX values obtained from test 
and retest were significant in both ADM and TA muscles. (P < 0.01)  
There was a significant correlation between MUNIX and CMAP amplitude 
in both ADM (r = 0.918, P < 0.01) and TA (r = 0.850, P < 0.01) muscles in 
ALS patients (Figure 1, A and B). In normal controls, there was also a 
significant correlation between MUNIX and CMAP amplitude in both ADM 
(r = 0.629, P < 0.01) and TA (r = 0.894, P < 0.01) muscles (Figure 1, C and 
B). 
In ALS patients, the MUNIX significantly correlated with the ALSFRS in 
the ADM (r = 0.439, P = 0.015), but not in the TA (r = 0.357, P= 0.053) 
(Figure 2, A and B). There was a significant correlation between MUNIX and 
MRC sum score in the TA (r = 0.474, P < 0.01) muscle, but not in the ADM 
(r = 0.349, P = 0.058) muscle (Figure 2, C and D). In both ADM and TA 
muscles of ALS patients, MUNIX values were lower in the weaker muscles, 
but the range was variable in muscles with mild weakness―MRC Grade IV, 
IV+, and V (Figure 2, E and F) 
Finally, the mean values of all 4 muscles were analyzed in the same way. 
There was a more significant correlation between CMAP and MRS sum score 
(r = 0.480, P < 0.01) and between CMAP and ALSFRS (r = 0.517, P < 0.01). 
There was also a more significant correlation between MUNIX and MRS sum 







Table 1. The characteristics of ALS patients and healthy controls 





Male 19 14  
Female 11 13  
Mean age (years) 57.33 (31-77) 55.04 (27-75) 
 
0.505 
Mean duration of 
symptoms (months) 
 
15.5 (3-41)   
Mean CMAP (mV) 
  bilateral ADM 
  bilateral TA 
 
 
5.65 ± 3.48 
3.10 ± 1.83 
 
11.07 ± 2.64 






  bilateral ADM 
  bilateral TA 
 
 
67.45 ± 53.03 
62.98 ± 41.44 
 
155.22 ± 46.97 




Mean MRC sum score 49.2 (23-59)   
Mean ALSFRS score 35.7 (16-45)   
Mean age, mean duration of symptoms, MRC sum score, and ALSFRS score 
are given together with the range (maximum MRC sum score 60; maximum 










































1 54 F Probable LS 7 35 51 
2 71 F Probable-lab B 16 34 46 
3 63 F Probable C 9 42 49 
4 70 F Definite B 12 35 52 
5 67 F Probable C 13 38 55 
6 73 F Probable C 10 29 43 
7 77 F Probable-lab B 9 45 56 
8 48 F Probable C 12 42 56 
9 63 F Definite C 14 24 45 
10 51 F Definite B 15 29 50 
11 57 F Definite C 20 16 40 
12 57 M Probable C 36 24 32 
13 63 M Probable-lab LS 12 44 55 
14 58 M Probable-lab B 13 44 58 
15 61 M Probable C 25 29 36 
16 62 M Probable-lab C 14 43 44 
17 45 M Definite C 6 29 52 
18 71 M Probable C 13 43 59 
19 47 M Probable LS 16 37 53 
20 58 M Probable-lab C 24 36 52 
21 54 M Probable C 13 44 46 
22 65 M Probable-lab C 11 40 42 
23 63 M Probable C 8 45 59 
24 61 M Probable C 12 39 57 
25 43 M Probable-lab LS 19 28 45 
26 31 M Definite C 3 38 50 
27 37 M Probable-lab LS 41 20 23 
28 53 M Probable C 5 43 58 
29 47 M Probable-lab C 26 36 56 
30 50 M Definite LS 31 41 56 
C, LS, and B refer to the cervical, lumbosacral and bulbar region, respectively. The duration of 








































1    
MUNIX 
2 
1 IV 3.3 3.3 25 22 IV+ 7.3 7.5 132 138 
2 III 3.6 3.7 26 26 IV 6.2 6.1 66 70 
3  IV- 6.4 6.6 48 46 II 3.6 3.3 10 5 
4 IV 9.6 9.6 118 132 IV 1.7 1.7 17 16 
5 IV 4.6 4.4 39 35  IV+ 4.4 4.5 57 62 
6 III 0.5 0.5 6 6 IV- 3 3 30 31 
7 V 8.5 8.3 141 108 V 7 6.9 78 77 
8  III+ 3.3 3.3 35 35 III- 2.4 2.4 22 22 
9 II 0.9 0.9 18 18 I 0.6 0.6 8 8 
10 III 1.8 2.3 26 34 IV 6.5 6.8 137 150 
11 II 1 1.2 14 20 II 0.5 0.7 5 9 
12 II 3.8 3.9 18 17 III 8.7 8.6 109 123 
13  IV+ 11.2 10.9 119 135 V 9.5 9.2 145 171 
14 V 12.7 13 178 170 V 10.3 10.5 103 95 
15 II 1.9 1.8 34 14 II 0.5 0.6 2 3 
16 III 8.4 8.5 130 155 II 4.6 4.7 34 42 
17 IV 9.9 9.5 93 72 II 5.7 5.8 35 34 
18  IV+ 6.5 6.4 56 58 V 5.1 5 67 87 
19 V 13.1 13.1 216 194 V 10.9 11 168 169 
20 I 1.7 1.7 21 21 II 4.2 4.2 48 57 
21 V 9.3 9.2 139 151 III 1.5 1.5 23 21 
22 III 4 4.5 40 52 III 4 4 40 41 
23  IV+ 13 13.7 121 144 IV- 6.8 7.5 64 68 
24 III 3.4 3.6 28 43 IV- 6.6 6.8 61 72 
25 II 1.6 1.5 9 9 IV 7.9 8.6 135 140 
26  IV+ 9.3 9.2 122 114  IV+ 10.3 10.4 156 128 
27  IV+ 7.1 7.3 85 75 IV- 3.2 3.3 16 15 
28  IV+ 7.3 7.6 127 143 IV- 4.9 5.2 58 63 
29 IV 2.4 2.3 40 35 IV 6.9 6.5 31 26 
































1    
MUNIX 
2 
1 IV 4 4 68 68 IV+ 6.7 6.6 136 125 
2 III+ 2 2 29 26 III- 1.8 1.8 40 40 
3 V 2.1 2.2 40 42 V 2.1 2.1 44 44 
4 V 2.2 2.3 50 52 V 1.8 1.8 43 53 
5 V 3.4 3.4 97 97 V 3.2 3.2 80 80 
6 IV- 1 1 24 26 IV- 1.9 1.8 39 37 
7 IV 2 1.9 38 37 IV 1.9 1.9 40 37 
8 V 6 6.1 119 135 V 6.3 6.1 113 115 
9 IV+ 4.4 4.7 85 86 IV 4.6 4.7 89 86 
10 IV 2.3 2.7 16 20 IV 2.6 2.7 41 45 
11 III 0.8 1 24 26 IV- 2.8 3 34 38 
12 III 4.8 4.4 68 59 III 5.6 5.7 103 122 
13 IV 3.8 3.8 41 34 IV+ 3.8 3.5 37 42 
14 V 5.7 6 102 114 V 5.9 6 106 109 
15 III 0.9 0.9 14 14 III 0.6 0.5 8 6 
16 IV- 4.8 4.7 66 57 III 4.4 4.1 100 89 
17 IV 4.2 4.2 64 68 IV 3.3 3.5 61 65 
18 IV 1.7 1.6 38 37 IV 2.7 2.7 53 51 
19 IV 3.3 3.3 95 95 IV 3.7 3.7 79 79 
20 V 4.4 4.4 75 75 III 1.4 1.4 15 15 
21 V 1.2 1.2 28 26 V 2 2 36 35 
22 V 0.7 0.8 12 11 V 1.4 1.4 16 13 
23 V 3.6 3.6 120 120 V 2 2 143 143 
24 V 3 2.9 58 59 V 3.5 3.5 73 72 
25 II 1.4 1.4 24 24 II 1 1 29 29 
26 V 5.4 5.5 129 127 V 5.3 5.4 128 121 
27 I 0.7 0.7 10 10 I 0.6 0.6 11 11 
28 V 5.8 6.2 126 131 IV+ 8.5 8.8 204 230 
29 IV+ 3 2.8 54 44 IV+ 3.7 3.5 75 70 







Table 5. The reproducibility of MUNIX measurements in ALS patients 

























































Figure 1. MUNIX values plotted against the CMAP amplitude of the 
muscle tested in ALS patients and normal controls―bilateral ADM 
muscles (A, C) and bilateral TA muscles (B, D)  











Figure 2. The mean MUNIX value of bilateral muscles plotted against the 
ALSFRS (A, B) and MRC sum score (C, D). MUNIX values are plotted 
against the power levels of the ADM and TA muscles graded on the MRC 
scale (E, F) 






















Figure 3. The mean CMAP and MUNIX values of 4 muscles plotted 















In this study, we showed the reproducibility of MUNIX of the TA muscle in 
ALS patients and found a good correlation between MUNIX and CMAP in 
both ADM and TA muscles The mean and lower limit values in normal 
controls were almost the same as those reported by Nandedkar et al. (15).  
 The reproducibility test showed some interesting results. The COV of 
MUNIX was higher for the ADM muscle than for the TA muscle in both ALS 
patients and normal controls, and it was higher in normal controls than in ALS 
patients in both muscles. The COV of CMAP showed similar findings. These 
results are slightly different from those of previous study (16). COV values 
usually expected to be high when the MUNIX is low. However, our results 
showed lower COVs in lower MUNIX values. Previous studies showed 
relatively variable MUNIX measurements compared to ours. The COVs were 
generally lower in our study than in previous studies. Our MUNIX values also 
showed relatively uniform values. The reason for this result may be due to the 
different skill of EMG technicians or the small sample size. The TA muscle is 
relatively difficult to take clear CMAPs compared to the ADM muscle. A 
nerve conduction study of the TA muscle was done by stimulating the 
peroneal nerve below the fibula head. Strong stimuli are needed because the 
nerve lies deep in the muscle. For this reason, the CMAPs are relatively lower 
in the TA muscle than in the ADM muscle (17). This technical difficulty may 
have produced relatively uniform CMAP values in our study. To reduce this 
effect, a larger sample size will be needed. 
18 
 
Consistent with previous investigations, the MUNIX well correlated with 
CMAP amplitude in normal controls as well as in ALS patients. However, 
there have been few reports to evaluate the MUNIX of the TA muscle in ALS 
patients. However, a recent study of prior polio patients evaluated the 
MUNIX and CAMP of the TA muscle and showed a good correlation 
between MUNIX and CMAP (11).   
In our study, MUNIX values significantly correlated with ALSFRS in the 
ADM muscle, but not in the TA muscle. The ALSFRS score consists of 
functions affected by the bulbar, cervical, thoracic, and lumbosacral segments 
(18). However, the majority of scores are related to respiratory function and 
weakness of the upper extremities. Respiratory function may be largely due to 
weakness of the bulbar segment, but the lumbosacral segment is located 
distant from the bulbar segment than from the cervical segment. The TA is a 
muscle of the lower extremity which is innervated by roots of the lumbosacral 
segment. Thus, the MUNIX of the TA mainly reflects the function of the 
lower extremity, not the bulbar or cervical function which is a major part of 
the ALSFRS. However, most ALS patients progress to advanced stages, and 
all segments can be affected. Therefore, if the enrolled number of patients was 
sufficiently large, the results may have shown a good correlation even in the 
TA muscle. This is a coincidence with recent studies that reported the 
spreading pattern of symptoms (19-21). 
 The correlation between MUNIX and MRC sum score was statistically 
significant in the TA muscle, but not in the ADM muscle. The TA is a large 
muscle compared to the ADM and is a proximal muscle with more abundant 
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muscle mass. Because of these characteristics of the TA, it may be more 
strongly related to the MRC sum score. This fact supports the hypothesis that 
the MUNIX in a large muscle more efficiently predict the progression of 
weakness. A previous study has evaluated the MRC sum scores in ALS 
patients by summing the muscle power levels of upper extremities (22), which 
was different from ours. In our study, MRS sum scores were calculated by 
summing the motor power levels of both upper and lower extremities. The 
MRC sum score has been widely used in clinical studies.    
The ALSFRS and MRC sum score reflect both upper and lower motor 
neuron functions (23), whereas the MUNIX assesses only lower motor 
function. For this reason, there are some limitations to the MUNIX for 
accurate evaluation of muscle activity in ALS patients.  
 We also found more significant correlations between the mean values of the 
4 muscles. Since ALS usually begins focally in the upper lower limb or bulbar 
muscles and then spreads to other regions, it might be beneficial to estimate 
the MUNIX in multiple muscles rather than in a single muscle. It is 
hypothesized that combined results of the 4 muscles will offset the distortion 
that may appear and show functional status. Our study results support this 
hypothesis. Therefore, this combination method can help predict disease 
progression regardless of onset regions. 
 MUNIX values were also found to be lower in the weaker muscles in ALS 
patients. Interestingly, the range of MUNIX values seems to be wider in 
moderately weak muscles, suggesting that the MUNIX has the potential to 
differentiate loss of motor units from compensatory reinnervation. There has 
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been some reports showing a decrease in the MUNIX in diseases other than 
ALS (24, 25). MUNIX values of motor neuron have been described in other 
diseases. 
 In conclusion, this study showed good correlations between MUNIX and 
CMAP/MRS sum score/MRC grade in the TA muscle. The pattern of their 
correlations in the TA muscle was not significantly different from that in the 
ADM muscle. The TA is a large muscle and easy to measure the MUNIX. 
Therefore, the MUNIX can also be used in large muscles in ALS patients. In 
addition, the mean values of bilateral ADM and TA muscles reflected 
functional status more precisely. They can help predict disease progression 
and survival. This is the first study that revealed the reproducibility and 
usefulness of the MUNIX in muscles of the 4 extremities. Further prospective 
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국   
 
: 근 축  삭경 증  신경퇴행  질  진행  운동신경 
소실  특징  한다. MUNIX(motor unit number index)는 근
축  삭경 증 자에  신경 축삭  손상 도를 평가할  있
는 새 운 진단 이다. 이 연구  목  근 축  삭경 증 
자  상 조군에  경골근과 소지외 근  이용한 MUNIX 검
사  재 과 용  증명하는 것이다. 
법: 30 명  근 축  삭경 증 자  27 명  상 조군에  
MUNIX 검사를 시행하 다. MUNIX, 복합운동근 동 , MRC 
근 지 , 근 축  삭경 증 임상 (ALSFRS)를 평가하고 
그들 사이  연  피어슨 상  분  통하여 계산하 다. ALS
자에  재  평가하  해  모든 근 에 하여 번씩 
하여 변동계 를 분 하 다. 또 4 가지 근  모  평균값  계
산하여 임상  상태  연  분 하 다.  
결과: 검사  재검사간에 복합운동근 동   MUNIX  평균
값  미한 차이가 없었다. 복합운동근 동  MUNIX  
26 
 
변동계 는 20% 이하  한 범 다. 근 축  삭경 증 
자에  소지외 근(r = 0.918, P < 0.01)과 경골근(r = 0.850, P 
< 0.01)모 에  MUNIX 값과 복합운동근 동  사이에 통계
 미한 상 계가 있었다. 상 조군에 도 소지외 근
(r = 0.629, P < 0.01)과 경골근(r = 0.894, P < 0.01)  
MUNIX  복합운동근 동 는 미한 상 계가 있었다. 
근 축  삭경 증 자에  소지외 근(r = 0.439, P < 0.015)
에 는 MUNIX  ALSFRS 간에 미한 상 계가 있었 나, 
경골근(r = 0.357, P < 0.053)에 는 미한 상 계가 없었
다. 경골근(r = 0.474, P < 0.01) 에 는 MUNIX  MRC 근
지  사이  미한 상 계가 있었 나소지외 근(r = 0.349, 
P = 0.058)에 는 미한 상 계가 없었다. 4 곳  근  평
균값  이용하여 분 하  , 복합운동근 동  MRC 
근 지   복합운동근 동  ALSFRS 사이에 미한 상
계가 있었 며, MUNIX  MRC 근 지   MUNIX  
ALSFRS 간에도 미한 상 계가 있었다. 
결 : 이 연구를 통해 근 축  삭경 증 자에  소지외 근과
경골근  이용한 MUNIX 검사가 운동신경 소실  효과  
해주는 것  인할  있었다. 소지외 근과 경골근 모  좋  
상 계를 보 나 MUNIX 상 계   약간 달랐다. 4 곳 
근  조합  자  능 상태  질병  진행  단하는데 좀  
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용하 다. 이 연구 결과를 뒷 침하  해 앞   많  자
를 포함하는 향  연구가 필요할 것이다. 
------------------------------------- 
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